An open-label, multicenter phase II trial of recombinant human endostatin, Endostar combined with cisplatin-based concurrent chemoradiation for stage IIB-IIIB cervical cancer with pelvic lymph nodes metastasis

Trial Profile

An open-label, multicenter phase II trial of recombinant human endostatin, Endostar combined with cisplatin-based concurrent chemoradiation for stage IIB-IIIB cervical cancer with pelvic lymph nodes metastasis

Recruiting
Phase of Trial: Phase II

Latest Information Update: 22 Sep 2017

At a glance

  • Drugs Endostatin (Primary) ; Cisplatin
  • Indications Cervical cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 22 Sep 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top